+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The impact of perioperative dexmedetomidine infusion on postoperative narcotic use and duration of stay after laparoscopic bariatric surgery

The impact of perioperative dexmedetomidine infusion on postoperative narcotic use and duration of stay after laparoscopic bariatric surgery

Journal of Gastrointestinal Surgery 11(11): 1556-1559

Dexmedetomidine (Precedex, Hospira, Lake Forest, IL) is an alpha-2 receptor agonist with sedative and analgesic sparing properties. This medication has not been associated with respiratory suppression, despite occasionally high levels of sedation. For 10 months, all patients undergoing a laparoscopic bariatric procedure received a dexmedetomidine infusion 30 min before the anticipated completion of the procedure (n = 34). A control group was comprised of a similar number of patients to have had laparoscopic bariatric surgery in the time period immediately before these 10 months (n = 37). All pathways and discharge criteria were identical for patients in each group. A total of 73 patients were included in this retrospective chart review. Two gastric bypass patients were excluded for complications requiring additional surgery (one bleed and one leak). Gastric bypass patients who received a dexmedetomidine infusion required fewer narcotics (66 vs 130 mg of morphine equivalents) than control patients and met discharge criteria on post-op day (POD) 1 more often (61% discharged POD 1 vs 26% discharged POD 1, p = 0.02). Vital signs and pain scores were similar in all groups. Dexmedetomidine infusion perioperatively is safe and may help to minimize narcotic requirements and decrease duration of stay after laparoscopic bariatric procedures. This may have important patient safety ramifications in a patient population with a high prevalence of obstructive sleep apnea. A well-organized prospective, randomized, double-blinded trial is necessary to confirm the benefits of dexmedetomidine suggested by this study.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 056369196

Download citation: RISBibTeXText

PMID: 17710502

DOI: 10.1007/s11605-007-0290-0

Related references

Dexmedetomidine versus morphine infusion following laparoscopic bariatric surgery: effect on supplemental narcotic requirement during the first 24 h. Surgical Endoscopy 30(8): 3368-3374, 2016

Standardized perioperative protocol with enhanced recovery after major laparoscopic bariatric surgery reduces length of stay, improves quality of care, and optimizes resources in high-volume bariatric unit. Surgery for Obesity and Related Diseases 6(2): 233-234, 2010

Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia and Analgesia 106(6): 1741-1748, 2008

Duration of Nil Per Os is causal in hospital length of stay following laparoscopic bariatric surgery. Surgical Endoscopy 31(4): 1901-1905, 2017

Effect of perioperative infusion of Dexmedetomidine combined with Sufentanil on quality of postoperative analgesia in patients undergoing laparoscopic nephrectomy: a CONSORT-prospective, randomized, controlled trial. Bmc Anesthesiology 18(1): 145, 2018

Early postoperative diet after bariatric surgery: impact on length of stay and 30-day events. Surgical Endoscopy 33(8): 2475-2478, 2019

Predictors of duration of postoperative hospital stay in patients undergoing advanced laparoscopic surgery. Surgical Laparoscopy Endoscopy and Percutaneous Techniques 15(2): 90-93, 2005

The impact of retractor SPONGE-assisted laparoscopic surgery on duration of hospital stay and postoperative complications in patients with colorectal cancer (SPONGE trial): study protocol for a randomized controlled trial. Trials 17(1): 132, 2016

Impact of Preoperative Anemia on Postoperative Kidney Function Following Laparoscopic Bariatric Surgery. Obesity Surgery 29(8): 2527-2534, 2019

Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. The Study of Perioperative Ischemia Research Group. Anesthesiology 82(3): 620-633, 1995

Comparison of laparoscopic versus conventional open cryptorchidectomies on intraoperative and postoperative complications and duration of surgery, anesthesia, and hospital stay in horses. Journal of the American Veterinary Medical Association 246(8): 885-892, 2015

The association of IVC filter placement with the incidence of postoperative pulmonary embolism following laparoscopic bariatric surgery: an analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Project. Surgery for Obesity and Related Diseases 15(1): 109-115, 2019

Length of stay by uncomplicated diabetes bariatric surgery patients: A laparoscopic adjustable banding versus laparoscopic sleeve gastrectomy. Journal of Evaluation in Clinical Practice 25(5): 779-787, 2019

Dexmedetomidine as an adjuvant for perioperative pain management in adolescents undergoing bariatric surgery: An observational cohort study. Journal of Pediatric Surgery 52(11): 1787-1790, 2017

Effect of intravenous infusion of dexmedetomidine on perioperative haemodynamic changes and postoperative recovery: A study with entropy analysis. Indian Journal of Anaesthesia 56(6): 542-546, 2012